Twenty regression analyses showing the independent associations of gender, level of intellectual disabilities, Down syndrome and age, with the top 20 physical health conditions (ORs (95% CIs))
Physical health condition | Gender | Level of disability | Down syndrome | Age | ||||||||
Ref=Male | Mild | Moderate | Severe | Profound | Ref: without | 16–24 | 25–34 | 35–44 | 45–54 | 55–64 | 65+ | |
Vision | 0.79 (0.61 to 1.02) | Ref | 1.12 (0.81 to 1.55) |
1.80 (1.27 to 2.57) |
2.57 (1.78 to 3.70) | 1.10 (0.79 to 1.53) | Ref | 0.83 (0.51 to 1.35) | 1.11 (0.71 to 1.73) | 1.05 (0.67 to 1.65) | 0.88 (0.55 to 1.42) | 0.77 (0.43 to 1.36) |
Obesity |
1.34 (1.03 to 1.73) | Ref | 0.78 (0.56 to 1.08) |
0.65 (0.46 to 0.94) |
0.30 (0.19 to 0.45) |
2.06 (1.47 to 2.88) | Ref | 1.35 (0.81 to 2.24) | 1.06 (0.66 to 1.70) |
1.78 (1.11 to 2.84) | 0.96 (0.58 to 1.60) | 1.21 (0.67 to 2.18) |
Epilepsy | 1.04 (0.79 to 1.38) | Ref |
1.57 (1.09 to 2.3) |
1.78 (1.21 to 2.62) |
4.49 (3.06 to 6.65) |
0.21 (0.13 to 0.34) | Ref |
1.74 (1.02 to 2.97) |
1.68 (1.02 to 2.75) | 1.23 (0.74 to 2.02) | 1.02 (0.60 to 1.74) | 0.68 (0.35 to 1.30) |
Constipation |
1.50 (1.14 to 1.97) | Ref | 1.26 (0.88 to 1.82) |
1.85 (1.27 to 2.70) |
4.30 (2.95 to 6.28) |
0.56 (0.38 to 0.82) | Ref | 1.38 (0.81 to 2.34) | 1.18 (0.72 to 1.94) | 1.59 (0.97 to 2.59) | 1.13 (0.67 to 1.92) | 1.15 (0.62 to 2.15) |
Ataxic/ gait disorder | 1.23 (0.92 to 1.64) | Ref |
2.40 (1.62 to 3.56) |
3.79 (2.51 to 5.67) |
6.66 (4.42 to 10.03) |
0.40 (0.26 to 0.62) | Ref | 1.43 (0.81 to 2.54) | 1.37 (0.80 to 2.34) |
1.78 (1.05 to 3.03) | 1.59 (0.90 to 2.78) |
2.59 (1.36 to 4.91) |
Hearing | 0.97 (0.73 to 1.30) | Ref | 0.94 (0.65 to 1.36) | 1.08 (0.73 to 1.61) | 0.86 (0.56 to 1.32) |
2.46 (1.74 to 3.49) | Ref | 0.71 (0.39 to 1.29) | 0.91 (0.54 to 1.54) | 1.22 (0.73 to 2.05) | 1.37 (0.80 to 2.38) |
4.59 (2.49 to 8.46) |
Nail disorder | 1.24 (0.92 to 1.66) | Ref | 1.01 (0.69 to 1.49) | 1.05 (0.70 to 1.59) | 0.9 (0.59 to 1.39) | 1.24 (0.85 to 1.80) | Ref |
1.95 (1.02 to 3.73) | 1.70 (0.92 to 3.12) |
2.92 (1.61 to 5.29) | 1.79 (0.94 to 3.41) |
2.41 (1.20 to 4.94) |
Epidermal thickening |
1.83 (1.34 to 2.50) | Ref |
1.49 (1 to 2.21) | 1.23 (0.79 to 1.92) | 1.32 (0.85 to 2.07) |
2.74 (1.91 to 3.93) | Ref |
2.87 (1.40 to 5.86) |
2.29 (1.16 to 4.53) |
2.94 (1.49 to 5.79) |
3.25 (1.60 to 6.59) |
2.34 (1.01 to 5.40) |
Cerebral palsy | 0.86 (0.61 to 1.22) | Ref |
2.38 (1.41 to 4.04) |
4.10 (2.43 to 6.86) |
9.86 (6.02 to 16.15) |
0.15 (0.07 to 0.32) | Ref | 1.62 (0.86 to 3.06) | 1.17 (0.63 to 2.14) | 1.25 (0.68 to 2.29) | 0.84 (0.43 to 1.63) | 0.63 (0.27 to 1.47) |
Osteoporosis |
2.34 (1.64 to 3.32) | Ref |
1.68 (1.01 to 2.82) |
2.67 (1.61 to 4.44) |
9.66 (6.01 to 15.54) |
0.22 (0.11 to 0.43) | Ref | 1.59 (0.77 to 3.26) |
2.11 (1.08 to 4.13) | 1.55 (0.78 to 3.08) |
2.40 (1.20 to 4.84) |
2.85 (1.30 to 6.27) |
Fungal infection | 0.85 (0.60 to 1.20) | Ref | 0.66 (0.43 to 1.03) | 0.76 (0.48 to 1.20) |
0.39 (0.22 to 0.69) |
1.68 (1.11 to 2.53) | Ref |
9.00 (3.09 to 26.20) |
3.77 (1.29 to 10.99) |
8.22 (2.89 to 23.39) |
6.40 (2.18 to 18.79) |
5.33 (1.66 to 17.11) |
Hypertension | 0.93 (0.65 to 1.33) | Ref |
0.65 (0.42 to 1.00) |
0.43 (0.25 to 0.72) |
0.31 (0.17 to 0.57) |
0.22 (0.10 to 0.46) | Ref | 2.11 (0.78 to 5.66) |
2.52 (1.01 to 6.30) |
4.49 (1.83 to 10.98) |
5.31 (2.15 to 13.16) |
7.74 (2.99 to 19.99) |
Bone deformity | 1.31 (0.92 to 1.85) | Ref | 1.37 (0.85 to 2.21) | 1.27 (0.76 to 2.13) |
2.96 (1.87 to 4.70) | 1.03 (0.65 to 1.64) | Ref | 1.22 (0.6 to 2.47) | 1.01 (0.52 to 1.98) | 1.58 (0.83 to 3.02) | 1.53 (0.77 to 3.04) | 2.06 (0.95 to 4.47) |
Musculoskeletal |
1.89 (1.32 to 2.70) | Ref |
0.54 (0.35 to 0.85) |
0.45 (0.27 to 0.74) |
0.16 (0.07 to 0.34) | 1.14 (0.73 to 1.79) | Ref | 2.35 (0.99 to 5.57) | 2.08 (0.92 to 4.70) |
3.10 (1.39 to 6.95) |
3.22 (1.40 to 7.41) | 2.31 (0.90 to 5.96) |
Eczema | 0.95 (0.66 to 1.35) | Ref | 0.62 (0.38 to 1.0) | 0.89 (0.55 to 1.45) | 0.92 (0.57 to 1.50) |
1.70 (1.12 to 2.59) | Ref | 1.04 (0.55 to 1.97) | 0.74 (0.40 to 1.36) | 0.890 (0.49 to 1.62) | 0.71 (0.36 to 1.38) | 0.81 (0.36 to 1.81) |
Gastro-oesophageal reflux disorder | 1.31 (0.91 to 1.87) | Ref | 0.85 (0.5 to 1.45) | 1.40 (0.84 to 2.35) |
3.36 (2.13 to 5.29) | 0.95 (0.59 to 1.53) | Ref | 1.05 (0.49 to 2.22) | 1.63 (0.84 to 3.18) | 1.80 (0.92 to 3.49) | 1.22 (0.58 to 2.55) | 1.21 (0.50 to 2.93) |
Dysphagia |
1.46 (1.01 to 2.12) | Ref |
2.35 (1.30 to 4.25) |
3.58 (1.99 to 6.44) |
10.50 (6.13 to 17.98) | 0.96 (0.58 to 1.59) | Ref | 1.24 (0.61 to 2.50) | 1.17 (0.60 to 2.27) | 1.04 (0.53 to 2.03) | 1.39 (0.69 to 2.8) | 0.94 (0.38 to 2.32) |
Lower respiratory tract infection | 0.9 (0.62 to 1.30) | Ref | 0.78 (0.46 to 1.32) | 0.76 (0.43 to 1.34) |
2.51 (1.58 to 3.99) |
1.87 (1.20 to 2.92) | Ref | 0.68 (0.35 to 1.32) | 0.64 (0.35 to 1.17) | 0.63 (0.34 to 1.17) | 0.63 (0.32 to 1.23) | 0.78 (0.34 to 1.78) |
Dyspnoea |
2.07 (1.42 to 3.03) | Ref | 0.95 (0.59 to 1.52) | 1.03 (0.63 to 1.69) |
0.38 (0.19 to 0.75) | 1.12 (0.70 to 1.8) | Ref | 1.25 (0.54 to 2.88) | 1.29 (0.60 to 2.77) |
2.43 (1.16 to 5.06) | 1.30 (0.57 to 2.94) | 2.30 (0.98 to 5.44) |
Dental health | 0.90 (0.62 to 1.31) | Ref | 0.88 (0.54 to 1.42) | 1.15 (0.70 to 1.88) | 0.65 (0.3 to 1.16) | 1.28 (0.80 to 2.04) | Ref | 1.90 (0.92 to 3.94) | 0.97 (0.47 to 2.01) | 1.51 (0.75 to 3.04) | 1.21 (0.56 to 2.58) | 1.31 (0.54 to 3.15) |
Numbers in bold are significant results.